ABL ATLASense Biotech Ltd. Executive Summary

ABL
ATLASense
Biotech Ltd.
Excellence in Bio Monitoring
Executive
Summary
ABL ES0114.4
About
ATLASense Biotech Ltd. is a privately
owned biomedical engineering spinoff
company. ABL draws on the IP and decades
of pioneering monitoring achievements of
Atlas Engineering (www.atlas-arl.com).
Our mission is to develop and produce
multi-parameter, connected health Vital
Signs Monitoring Systems Patch (Pat.
Pend.).
We envision that our flagship monitors will
become a significant backbone enabler in
emerging, next generation remote patient
monitoring markets.
Hospital Monitoring Market
The Physiologic Monitoring Systems market is
well-established, primarily as hospital-grade
means to help evaluate a patient’s condition
and make appropriate decisions.
The monitors display physiological signals,
including ECG, respiration, noninvasive blood
pressure (NIBP) and body temperature.
In-Hospital Monitoring Issues
Well-known problems associated with patient
monitors include: the need to shave the areas
under the electrodes; prepare the skin; tape
the wires to the body to minimize detaching.
Remote Patient Monitoring Market
Healthcare providers are now refocused on
curbing 30 day readmissions and keeping
patients out of hospitals by migrating to home
monitoring following discharge.
Remote patient monitoring (RPM), homecare
telehealth, is an emerging multi-billion dollar
mobile health market of real-time ambulatory
healthcare. It allows patients to be monitored
at home.
Telemetric (wireless) hospital monitoring
systems allow the patient to be moved within
transmission range without being
disconnected from central station monitoring
by eliminating the cables linking the patient to
the monitor.
Key players include Philips, Spacelabs and
Welch Allyn. The market size is projected to
exceed $4Billion by 2018.
Such monitors are expensive and often
require maintenance. And, some hospitals do
not have the personnel to interpret the
monitored data.
RPM is increasingly used with the elderly and
the chronically ill. RPM allow such patients
and their physicians to closely monitor
changing medical conditions and intervene, if
need be. This emerging market and its key
players are discussed in
http://ftp.jrc.es/EURdoc/JRC71141.pdf.
RPM could save the health care industry $700
billion over 15 to 20 years and help hospitals
avoid costly readmissions. .
1
ATLASense RPM Solution
DESCRIPTION
ATLASense is in advance development stages of
a pioneering, disposable, low cost RPM patch,
the ABL8200i. Unmatched in comprehensive
monitoring performance with a tiny patch, it
comprises high level integration: A sensors;
signal processing; wireless communication;
battery and adhesive.
The ABL8200i is a derivative of market-proven
Atlas Engineering workhorse platform, AR7000.
FEATURES & BENEFITS
 Motion tolerant shave free ECG
 Cuffless relative blood pressure trending
 Shared parameters sensors
 Wireless BTLE transmission
 End-to-end gateway
 Skin pigment insensitive pulse sensor
 Wire-free, low-profile, non obtrusive
 Proprietary algorithms
 Disposable, 2 weeks operation
 Continua Health Alliance compatible
 Open protocol for 3rd party applications
developers*
SINGLE SITE MONITORED
PARAMETERS
ECG; EMG; Respiration; Pressure pulse
wave; Ambient and surface body
temperature; Skin Conductance; Tri-axial
acceleration /activity/position; Stethoscope
heart/lung sounds.
DERIVED PARAMETERS &
ALGORITHMS
ECG HR/ HRV/ Arrhythmia/Tachycardia/
Bradycardia; PTT (Relative BP enabler);
Sweat; Hypothermia/Hyperthermia;
Body position/Fall detection.
3rd PARTY MONITORING
APPLICATIONS
 Pre-surgery status home
monitoring
 First responders' triage
 Elderly/chronically-ill home
monitoring
 Remote checkup
 Quality of sleep and sleep
disorders
* Embedded software applications and integration of
 Functioning of implants
monitoring modules (e.g., blood pressure, glucose, weight
 Consumer fitness and wellness
and multi-lead ECG).
 Epileptic events
 Medication efficacy and
VALUE PROPOSITION
compliance
 Having an early indication of a risk factor Neuromuscular rehabilitation
cardiac, stroke, respiratory, inflammation Tracking emotions
at home
 Fall detection
 Built-in fall detector
 Hypoglycemia
 Minimizing hospital readmission
 Cardiac arrhythmia
 Tracking medication efficacy
 Apnea
 Peace of mind of real-time monitoring
 Pre-Eclampsia (Pregnancy The patch will cost under $10 to produce.
induced hypertension)
ABL SCREENING APPLICATIONS
 Cardiac arrhythmias
 Sleep apnea
2
NEAREST COMPETITION
ABL is more comprehensive in monitoring
changes in vital signs, and a low cost disposable.
iHealth wearable
blood pressure
vest and
smartphone ECG.
Lifewatch multiple
patch
V-Patch, ECG
only
WHY ATLASense
ATLASense starts with over 3 decades of licensor's
knowhow, global achievement record and reputation,
customers, IP, and FDA experience.
WHY NOW
The time for ABL patch is now- currently no direct
competition on the market, unique value proposition for
commercial success.
TEAM
Founded by Dan Atlas (www.atlas-arl.com), a veteran
biomedical and engineering expert with engineering cofounders, backed by multidisciplinary team of advisors
exceeding 300 man-years of top multidisciplinary talent:
Bioengineering, business and medical expertise. CV's
available under NDA.
FINANCIAL DATA
Available under NDA.
CONTACT PERSON Dan Atlas +972.50.779.5686 mailto: [email protected]
3

Download Report